Cancer prevention: Major initiatives and looking into the future

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 10, Issue 2, 2010, Pages 143-154

  Gotay, Carolyn Cook ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer prevention; Genetics; Health disparities; Obesity; Smoking; Social determinants; Vaccine

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BRCA1 PROTEIN; BRCA2 PROTEIN; CURCUMIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FINASTERIDE; GENISTEIN; GREEN TEA EXTRACT; HEPATITIS B VACCINE; LYCOPENE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; OMEGA 3 FATTY ACID; PLACEBO; POMEGRANATE EXTRACT; RALOXIFENE; RESVERATROL; RETINOL; SELENIUM; TAMOXIFEN; WART VIRUS VACCINE;

BLOOD CLOTTING DISORDER; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CHEMOPROPHYLAXIS; CIGARETTE SMOKING; COHORT ANALYSIS; ERECTILE DYSFUNCTION; GYNECOMASTIA; HEREDITY; HUMAN; IMPOTENCE; INFECTION; LIFESTYLE; LUNG CANCER; MENOPAUSAL SYNDROME; NUTRITION; OBESITY; PHYSICAL ACTIVITY; PREVENTIVE MEDICINE; PROSTATE CANCER; REVIEW; SEXUAL BEHAVIOR; SIDE EFFECT; SMOKING CESSATION PROGRAM; SOCIAL ASPECT; STROKE; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; UTERUS CANCER;

CHEMOPREVENTION; HUMANS; LIFE STYLE; NEOPLASMS; OBESITY; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RISK FACTORS; SMOKING;

EID: 77950985597     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.10.9     Document Type: Review

References (70)

1. World Health Organization. World Cancer Report 2008. WHO, Geneva, Switzerland (2008).
2. Yancik R. Population aging and cancer: a cross-national concern. Cancer J. 11(6), 437-441 (2005). (Pubitemid 43097070)
3. Bray F, McCarron P, Parkin D. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 6(6), 229-239 (2004). (Pubitemid 39440251)
4. Weir HK, Thun MJ, Hankey BF et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl Cancer Inst. 95(17), 1276-1299 (2003).
5. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Acitivity, and the Prevention of Cancer: a Global Perspective. WCRF International, London, UK (2007).
6. Bray F, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int. J. Cancer 126(6), 1454-1466 (2010).
7. Doll R, Peto R. The causes of cancer: quantitative estimates of aviodable risks of cancer in the United States today. J. Nat. Cancer Inst. 66, 1191-1308 (1981). (Pubitemid 11063920)
8. Soerjomataram I, De Vries E, Pukkala E, Coebergh JW. Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change. Int. J. Cancer 120(6), 1336-1343 (2007). (Pubitemid 46256789)
9. Danaei G, Vander Hoorn S, Lopez A, Murray CJ, Zzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366(9499), 1784-1793 (2005). (Pubitemid 41642642)
10. Platz E, Willett WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 11(7), 579-588 (2000). (Pubitemid 30636357)
11. Parkin D. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030-3044 (2006).
12. Bhalta N, Classen M, Denny L et al. Protection Against Cancer-Causing Infections. World Cancer Campaign 2010. Geneva, Switzerland (2010).
13. Fulfilling the Potential of Cancer Prevention and Early Detection. Curry S, Byers T, Hewitt M (Eds). National Academies Press, Washington, DC, USA (2003).
14. Guindon G, Boisclair D. Past, current and future trends in tobacco use. The World Bank, Washington, DC, USA (2003).
15. Agency for Healthcare Research and Quality. Systems Change: Treating Tobacco Use and Dependence. Based on the Public Health Service (PHS) Clinical Practice Guideline-2008 Update. Agency for Healthcare Research and Quality, MD, USA (2009).
16. Gotay CC. Behavior and cancer prevention. J. Clin. Oncol. 23(2), 301-310 (2005).
17. Shafey O, Dolwick S, Guidon GE. Tobacco Control Country Profiles 2003. WHO, Geneva, Switzerland (2003).
18. Office on Smoking and Health NCfCDPaHP. Trends in Current Cigarette Smoking Among High School Students And Adults, United States, 1965-2007. Centers for Disease Control and Prevention, GA, USA (2009).
19. Centers for Disease Control and Prevention (CDC). Ten Great Public Health Achievements - United States 1900-1999. Morbid. Mortal. Wkly Rep. 48, 241-243 (1999).
20. World Health Organization Europe. The European Tobacco Control Report 2007. WHO, Geneva, Switzerland (2007).
21. World Health Organization. WHO Reoprt on the Global Tobacco Epidemic, 2008: The MPOWER Package. WHO, Geneva, Switzerland (2008).
22. International Union Against Cancer. UICC Population Survey Of Cancer-Related Beliefs And Behaviours. International Union Against Cancer, Geneva, Switzerland (2008).
23. Willett WC. Diet, nutrition and, avoidable cancer. Environ. Health Perspect. 103(Suppl. 8), 165-170 (1995).
24. Boffetta P, Hashibe M, La VC, Zatonski W, Rehm J. The burden of cancer attributable to alcohol drinking. Int. J. Cancer 119(4), 884-887 (2006). (Pubitemid 44051453)
25. Rehm J, Rehn N, Room R et al. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur. Addict. Res. 9(4), 147-156 (2003). (Pubitemid 37140369)
26. Room R, Graham K, Rehm J, Jernigan D, Monteiro M. Drinking and its burden in a global perspective: policy considerations and options. Eur. Addict. Res. 9(4), 165-175 (2003). (Pubitemid 37140371)
27. Ministerial Council Strategy Development Team. National Alcohol Strategy 2006- 2009. Ministerial Council, Canberra, Australia (2006).
28. Department of Health SSaPS. Strategy For Reducing Alcohol Related Harm. Department of Health SSaPS, Scotland, UK (2000).
29. WHO/FAO Expert Consultation. Diet, Nutrition and the Prevention of Chronic Diseases. WHO/FAO Expert Consultation, Geneva, Switzerland, 916 (2002).
30. Hall JN, Moore S, Harper SB, Lynch JW. Global variability in fruit and vegetable consumption. Am. J. Prev. Med. 36(5), 402-409 (2009).
31. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch. Intern. Med. 169(6), 562-571 (2009).
32. Walker P, Rhubart-Berg P, McKenzie S, Kelling K, Lawrence RS. Public health implications of meat production and consumption. Public Health Nutr. 8(4), 348-356 (2005). (Pubitemid 40835270)
33. Delgado CL. Rising consumption of meat and milk in developing countries has created a new food revolution. J. Nutr. 133(11 Suppl. 2), 3907S-3910S (2003).
34. Popkin BM. Reducing meat consumption has multiple benefits for the world's health. Arch. Intern. Med. 169(6), 543-545 (2009).
35. Calle EE, Rodriguez C, Walker- Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348(17), 1625-1638 (2003). (Pubitemid 36459468)
36. Banegas JR, Lopez-Garcia E, Gutierrez- Fisac JL, Guallar-Castillon P, Rodriguez- Artalejo F. A simple estimate of mortality attributable to excess weight in the European Union. Eur. J. Clin. Nutr. 57(2), 201-208 (2003). (Pubitemid 36240470)
37. World Health Organization. Obesity and Overweight. WHO, Geneva, Switzerland (2006).
38. Lemmens VEPP, Oenema A, Klepp KI, Henriksen HB, Brug J. A systematic review of the evidence regarding efficacy of obesity prevention interventions among adults. Obesity Rev. 9(5), 446-455 (2008).
39. McLean RM, Hoek JA, Buckley S et al. 'Healthy Eating - Healthy Action': evaluating New Zealand's obesity prevention strategy. BMC Public Health 9, 452 (2009).
40. Blom R, Nikogosian H. Steps to Health: A European Framework to Promote Physical Activity for Heath. WHO Regional Office for Europe, Copenhagen, Denmark (2007).
41. Plotnikoff RC, Fein A, Milton L, Prodaniuk T, Mayes V. Workplace physical activity framework. University of Alberta, AB, USA (2003).
42. Sports and Recreation Victoria. The Active for Life Physical Activity Framework. Sports and Recreation Victoria, Victoria, Australia (2000).
43. Warner KE. The role of research in international tobacco control. Am. J. Public Health 95(6), 976-984 (2005). (Pubitemid 40740707)
44. Pagliusi S. Initative for Vaccine Research. World Health Organization, Geneva, Switzerland (2009).
45. Alliance for Cervical Cancer Prevention. Improving Women's Health And Saving Lives Through Cervical Cancer Prevention Programs In Developing Countries. Alliance For Cervical Cancer Prevention, NY, USA (2005).
46. European Cervical Cancer Association. HPV Vaccination Across Europe. European Cervical Cancer Association. Lyon, France (2009).
47. Petaja T, Keranen H, Karppa T et al. Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04- adjuvanted vaccine in healthy boys aged 10-18 years. J. Adolescent Health 44(1), 33-40 (2009).
48. De Kok IM, Van BM, Habbema JD. Cost-effectiveness analysis of human papillomavirus vaccination in The Netherlands. J. Natl Cancer Inst. 101(15), 1083-1092 (2009).
49. Lippman SM, Hawk ET. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 69(13), 5269-5284 (2009).
50. Greenwald P. Cancer chemoprevention. BMJ 324, 714-718 (2002).
51. Lippman SM, Klein EA, Goodman PJ et al. Effect of selenium and vitamin e on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J. Am. Med. Assoc. 301(1), 39-51 (2009).
52. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of b-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334(18), 1150-1155 (1996).
53. Amin ARMR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol. 27(16), 2712-2725 (2009).
54. Fisher B, Constantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst. 90(18), 1371-1388 (1998). (Pubitemid 28439961)
55. Fisher B, Costantino JP, Wickerham DL et al. Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst. 97(22), 1652-1662 (2005). (Pubitemid 41672231)
56. Anand P, Kunnumakara AB, Sundaram C et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 25(9), 2097-2116 (2008).
57. Cummings SR, Eckert S, Krueger KA et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. J. Am. Med. Assoc. 281(23), 2189-2197 (1999). (Pubitemid 29275701)
58. Ettinger B, Black DM, Mitlak BH et al. Reduction of verterbral fracture risk in postmenopausal women with oeseoporosis treated with raloxifene: results from a 3-year randomized clinical trial. J. Am. Med. Assoc. 282(7), 637-645 (1999). (Pubitemid 29384151)
59. Thompson IM, Goodman PJ, Tangen CM et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349(3), 215-224 (2003). (Pubitemid 36859473)
60. Jones LA, Chilton JA, Hajek RA, Iammarino NK, Laufman L. Between and within: international perspectives on cancer and health disparities. J. Clin. Oncol. 24(14), 2204-2208 (2006). (Pubitemid 46630693)
61. Frohlich KL, Ross N, Richmond C. Health disparities in Canada today: some evidence and a theoretical framework. Health Policy 79(2-3), 132-143 (2006). (Pubitemid 44529700)
62. World Cancer Research Fund/American Institute for Cancer Research. Policy and Action for Cancer Prevention. Food, Nutrition, Physical Activity: a Global Perspective. World Cancer Research Fund/ American Institute for Cancer Research, London, UK (2009).
63. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 285(5), 540-544 (2001). (Pubitemid 32656320)
64. Berrettini W, Bierut L, Crowley TJ et al. Setting priorities for genomic research. Science 304(5676), 1445-1447 (2004).
65. Merikangas KR , Risch N. Genomic priorities and public health. Science 302, 599-601 (2003). (Pubitemid 37310906)
66. Halliday JL, Collins VR, Aitken MA, Richards MP, Olsson CA. Genetics and public health - evolution, or revolution? J. Epidemiol. Community Health 58(11), 894-899 (2004).
67. Wang C, Miller SM, Egleston BL, Hay JL, Weinberg DS. Beliefs about the causes of breast and colorectal cancer among women in the general population. Cancer Causes Control 21(1), 99-107 (2009).
68. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes? Am. J. Epidemiol. 161(9), 799-805 (2005). (Pubitemid 40577833)
69. Howard P. Testing the leap-frog hypothesis: the impact of existing infrastructure and telecommunications policy on the global digital divide. Info. Comm. Soc. 10(2), 133-157 (2007).
70. Angell SY, Silver LD, Goldstein GP et al. Cholesterol control beyond the clinic: New York City's trans fat restriction. Ann. Intern. Med. 151(2), 129-134 (2009).